CEO & President of Wells Pharmacy Network, Kris Fishman, was honored to join BSS Global and the Outsourcing Facility Association (OFA) for a meaningful discussion focused on the future of compounding pharmacy and improving patient and provider access to the medications they need most
On the other hand, continued work on cannabinoids for medical use resulted in the Food and Drug Administrations (FDA) approval of cannabidiol (CBD), in the form of Epidiolex, for treating rare and severe forms of epilepsy, and of synthetic 9-9 tetrahydrocannabinol (THC), dronabinol, and nabilone, for preventing nausea and vomiting associated with chemotherapy
During, M
The booming class of GLP-1 drugs that includes Ozempic and Wegovy is not only effective for diabetes and obesity, but is also showing early potential to help with conditions involving the brain, like mental health disorders, Alzheimers, and even, as new study results suggest Parkinsons disease
If you take other medications - particularly diabetes medications, thyroid medications, or blood thinners - discuss potential interactions with your assigned clinical provider before starting a GLP-1 program
Novo Nordisk expands Wegovy access as FDA bans semaglutide copies Kimberly Redmond 22, 2025// The basics: Novo Nordisk offers Wegovy at $199 for new, self-pay patients Offer follows an FDA ban on compounded semaglutide drugs Company has filed nearly 120 lawsuits to block knockoff versions With a U.S